While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked GLP-1 (glucagon-like peptide-1) agonists — the class of drugs that includes semaglutides — to an increased risk of hair loss.

Intermittent fasting has long been a controversial weight loss technique. A new study looks at how effective it is compared to daily calorie counting.